Kalon raises underlying profits by 43% and confirms total dividend of 3.2p
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.KALON, the paint maker that failed in an attempt to buy its rival Manders last summer, has increased underlying profits by 43 per cent, writes Robert Cole.
Kalon did not make a profit forecast as part of its share-based attack on Manders. However, yesterday it confirmed the payment of a 3.2p total dividend that was promised as part of the bid.
Mike Hennessy, chief executive, said most of the growth came from greater operational efficiencies. This year, Kalon expects a profits boost from Novodec, the French paint maker it bought for pounds 20m last month.
Kalon made operating profits of pounds 13.2m, compared with pounds 9.2m. However, it suffered from a pounds 2.6m charge relating to the costs of the bid and from losses on the disposal of a chemicals operation.
The company published figures in line with the new FRS3 accounting standard, which includes the one-off costs in calculation of pre-tax profits and earnings per share.
Under FRS3, Kalon's earnings per share fell from 5.3p to 5.2p.
Kalon shares rose 1p to 142p yesterday. Kalon and Manders shares have both outperformed the market since the bid lapsed.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments